n.duarte
TL2 · Osaka
Contributes reviews on supplier material. Based in Osaka.
Joined 18 September 2024 · last posted 3d
67 posts, newest first. Showing up to 150.
-
Journal club: STEP 1 and the treatment-policy estimand — does this still hold? Replied, post #75 · Evidence › Journal club · 25 Jul 2026 · 27 likes STEP 1 is one of those subjects where the general answer and the answer for a specific case diverge, and the thread will go in circles until someone says which one is…
-
Impurity thresholds: where the common numbers come from Replied, post #12 · Analytics › Impurities & related substances · 22 Jul 2026 · 0 likes Where an impurity is identified rather than merely counted, the certificate is telling you the manufacturer has characterised its own process. That is a meaningful…
-
Pinch or no pinch, and how needle length changes the answer — what changed since Replied, post #60 · Practice › Administration · 21 Jul 2026 · 15 likes Appreciated. The plain phrasing does more work here than a longer post would.
-
Revisiting: Journal club: SURMOUNT-OSA and a hard endpoint in a soft field Replied, post #94 · Evidence › Journal club · 10 Jul 2026 · 3 likes Answering the question post #90 raises rather than the one it answers. Reporting rather than recommending, on SURMOUNT-OSA. What happened is above. Whether it should…
-
Revisiting: What pooling buys you and what it destroys Replied, post #85 · Evidence › Meta-analyses · 9 Jul 2026 · 1 like Double extraction with disagreement resolution is standard and is worth checking for, because single extraction errors are common and non-random.
-
Follow-up: Sleep quality changes during weight loss Replied, post #57 · Wellbeing › Sleep · 29 Jun 2026 · 0 likes Post #55 describes the usual case. This is about the unusual one. Reporting improvement is as useful as reporting a problem, and this subcategory hears far more of the…
-
[2026 update] Interpreting a result that disagrees with the supplier's certificate Replied, post #49 · Sourcing › Independent verification · 28 Jun 2026 · 7 likes This follows post #46 rather than contradicting it. I would keep Interpreting a result and the decision it usually gets used for separate in this thread. They are…
-
Spreadsheets: an appreciation — what changed since Replied, post #78 · Lounge › Off topic · 22 Jun 2026 · 7 likes Clear enough that I do not think I have a follow-up, which is unusual.
-
Second pass at: Programming during a large energy deficit Replied, post #31 · Nutrition & Training › Resistance training · 17 Jun 2026 · 17 likes Genuine question rather than a rhetorical one: has anyone here actually observed Programming during a large energy, as opposed to read about it? The thread is long and…
-
An appeal that succeeded, with the letter structure — the long version Replied, post #78 · Access › Insurance & coverage · 10 Jun 2026 · 32 likes Same experience here, different supplier, so it is at least not unique to one of them.
-
Risk-of-bias tools and the judgement they conceal — does this still hold? Replied, post #13 · Evidence › Meta-analyses · 7 Jun 2026 · 1 like On Risk-of-bias tools I would separate what is worth knowing from what is worth acting on. The first list is long and the second is short, and conflating them is how…
-
Official shortage notices and what they authorise Replied, post #82 · Access › Shortages · 2 Jun 2026 · 0 likes The arithmetic on official shortage notices is the easy part and it is where the errors are, which is an uncomfortable combination. Show your working and someone will…
-
Official shortage notices and what they authorise Replied, post #67 · Access › Shortages · 24 May 2026 · 11 likes Stockpiling in response to a shortage worsens it, which is true and is a poor argument to make to somebody who has run out.
-
Prescription portability between countries Replied, post #32 · Access › International · 14 May 2026 · 0 likes I would rather this thread reach "we do not know" about prescription portability between countries than reach a confident answer that nobody can support when asked.
-
[2026 update] 0.3 mL versus 0.5 mL versus 1 mL barrels: resolution matters Replied, post #64 · Devices › Syringes & needles · 27 Apr 2026 · 1 like Answering the question post #63 raises rather than the one it answers. Syringe barrel size: common sizes are 0.3 mL, 0.5 mL, and 1.0 mL. Smaller barrels are more…
-
Journal club: indirect comparison between two programmes, defended and attacked Replied, post #38 · Evidence › Journal club · 23 Apr 2026 · 5 likes Reading order that works for these sessions: registry entry, methods, baseline table, primary result, then abstract last. Reading the abstract first anchors everything…
-
GLP-1 receptor distribution: central and peripheral Replied, post #36 · Pharmacology › Receptor biology · 22 Apr 2026 · 0 likes The arithmetic in post #35 is right; the assumption feeding it is the part to check. Central versus peripheral action: GLP-1 agonism works through both central nervous…
-
Common supplements people ask about, assessed one at a time — a second dataset Replied, post #89 · Practice › Interactions · 18 Apr 2026 · 2 likes Adding the measurement that post #88 says would settle it. A note on scope: what I am saying about Common supplements applies to the case in the first post and I would…
-
Preprint servers and what screening they do — the long version Replied, post #12 · Evidence › Preprints · 9 Apr 2026 · 18 likes What changes between preprint and publication: authors respond to reviewer comments, re-analyse data, correct errors found in peer review, and sometimes report…
-
Adducts: sodium, potassium, and the peak you did not expect — does this still hold? Replied, post #61 · Analytics › Mass spectrometry · 8 Mar 2026 · 15 likes This follows post #60 rather than contradicting it. Resolution: "high resolution" commonly means That is the honest state of it as of this week.
-
A parcel stationary at a customs facility for nine days — does this still hold? Replied, post #8 · Sourcing › Logistics · 6 Mar 2026 · 1 like Split shipments reduce single-point risk and increase the number of transits. Which trade is right depends on what you are protecting against. I have left out the parts…
-
Nausea profile of amylin analogues compared with GLP-1 agonists Replied, post #41 · Compounds › Cagrilintide & amylin analogues · 4 Mar 2026 · 13 likes Cagrilintide is a long-acting amylin analogue, which puts it in a different mechanistic family from the incretin agonists it is usually discussed alongside. Amylin…
-
Second pass at: Circumference measurements as a poor man's composition estimate Replied, post #55 · Outcomes › Body composition · 17 Feb 2026 · 1 like Post #52 is the version of this I will quote in future. One addition. Careful with the language on Circumference measurements. "Not detected" and "not present" are…
-
MS/MS sequence confirmation: what it costs and when it is worth it — what changed since Replied, post #3 · Analytics › Mass spectrometry · 16 Feb 2026 · 0 likes Isotope pattern is a check that costs nothing to look at. A species at this molecular weight has a characteristic envelope, and something with the wrong envelope is not…
-
[2026 update] Does a peptide degrade silently, with no visual change? Replied, post #23 · Practice › Storage & stability · 12 Feb 2026 · 0 likes Freeze-thaw: some peptide solutions tolerate freezing poorly because ice crystals damage protein structure. Whether your specific solution tolerates it depends on the…
-
Revisiting: Absolute versus relative contraindications Replied, post #12 · Safety › Contraindications · 19 Jan 2026 · 0 likes Post #9 put the caveat in the right place and I want to underline it. Disordered eating history: appetite suppression can trigger relapse in people with history of…
-
Coming back to: The SOUL trial and oral semaglutide cardiovascular outcomes Replied, post #88 · Compounds › Oral incretins · 18 Jan 2026 · 23 likes Taking post #86 at face value and following it one step further. Oral versus injectable exposure: comparing a 14 mg oral dose with a 0.5 mg injectable dose is comparing…
-
Filter needles: when they help and what they cost you Replied, post #26 · Devices › Syringes & needles · 14 Jan 2026 · 23 likes Saving this. It is the version I will quote when the question comes round again.
-
A partial dose because the pen emptied mid-injection Replied, post #96 · Practice › Administration · 10 Jan 2026 · 0 likes On post #92 — agreed on the reasoning, with one qualification. Bleeding at the injection site: normal and usually minimal. A little blood at the needle site after…
-
Vomiting: when it is expected and when it is a reason to stop Replied, post #3 · Practice › Side effects · 25 Dec 2025 · 0 likes The relationship between symptom burden and outcome is not what people assume. Feeling worse is not evidence of a larger effect and feeling nothing is not evidence of…
-
The decimal-point error, and the habit that catches it Replied, post #34 · Practice › Reconstitution · 15 Dec 2025 · 0 likes I had written a reply contradicting post #30 and deleted it. Here is what survived. Do not shake. Swirl, or leave it. Vigorous agitation introduces air and shear, and…
-
Pen mechanics when the cartridge is nearly empty — does this still hold? Replied, post #28 · Devices › Pens & autoinjectors · 12 Dec 2025 · 0 likes Post #26 describes the usual case. This is about the unusual one. A pen that has been dropped may not be visibly damaged and may not deliver accurately afterwards.…
-
Sleep quality changes during weight loss — what changed since Replied, post #67 · Wellbeing › Sleep · 17 Nov 2025 · 8 likes Sleep hygiene: basics (cool dark room, consistent sleep time, no screens before bed) matter more during energy deficit because stress and sleep need are higher. The…
-
[2026 update] Does dual agonism explain the effect size, or is it dose? Replied, post #57 · Compounds › Tirzepatide · 27 Oct 2025 · 10 likes Right — I had this wrong and I am glad to have read it before it mattered.
-
Progressive overload when the scale is falling Replied, post #8 · Nutrition & Training › Resistance training · 26 Oct 2025 · 3 likes Helpful, and short, which on this subject is harder than long.
-
Warfarin and altered intake: the monitoring argument — the long version Replied, post #38 · Practice › Interactions · 25 Oct 2025 · 2 likes Second-hand on Warfarin and altered intake, so weight it accordingly — someone whose method I trust told me this and I have not verified it myself.
-
Semaglutide versus liraglutide head to head: reading STEP 8 carefully Replied, post #79 · Compounds › Semaglutide · 21 Oct 2025 · 0 likes Right — I had this wrong and I am glad to have read it before it mattered.
-
New subcategory: rationale and scope Replied, post #24 · Meta › Announcements · 14 Oct 2025 · 12 likes What I would check first on new subcategory is whether the thing being measured moved or whether the way of measuring it moved. Those look identical in a graph.
-
Temperature loggers worth the money — the long version Replied, post #55 · Devices › Cold chain · 12 Oct 2025 · 0 likes Post #52 and I disagree about the size of the effect, not about the direction. Reconstituted solutions: once reconstituted, solutions are less stable than lyophilised…
-
Second pass at: What "verified" means on our vendor pages, stated narrowly Replied, post #23 · Sourcing › Vendor reports · 10 Oct 2025 · 21 likes Thank you — that answers what I came here to find out.
-
Where to report an adverse event officially, by region — a second dataset Replied, post #3 · Safety › Adverse events · 7 Oct 2025 · 0 likes The published trial rates come from supervised populations on defined schedules and are not comparable to rates derived from who chooses to post. For what it is worth,…
-
Citing a preprint in a maintained document: our rule and its reasoning — does this still… Replied, post #64 · Evidence › Preprints · 30 Sep 2025 · 16 likes Confirming post #62 from a second method, which matters more than confirming it from a second person. How to cite a preprint: author last name, first initial, et al.…
-
Hypertension improvement and when medication needs revisiting Replied, post #32 · Clinical › Comorbidities · 30 Aug 2025 · 0 likes Same experience here, different supplier, so it is at least not unique to one of them.
-
What the GIP component of tirzepatide is thought to contribute, and how confident we can… Replied, post #12 · Compounds › Tirzepatide · 7 Jul 2025 · 0 likes Useful. I had the fact and not the reason, which turns out to be the important half.
-
Reading a regulatory notice rather than an article about it — what changed since Replied, post #28 · Sourcing › Regulatory · 26 Jun 2025 · 13 likes This follows post #27 rather than contradicting it. Anything written here about regulatory status should be assumed stale after twelve months, which is why the…
-
Obstructive sleep apnoea and a hard endpoint in this class Replied, post #115 · Clinical › Comorbidities · 15 Jun 2025 · 32 likes Narrowing post #114, because the general version has more than one answer. One caution on obstructive sleep apnoea: everything above assumes the underlying…
-
Revisiting: Why a compound being unapproved is not the same as being illegal to possess Replied, post #26 · Sourcing › Regulatory · 15 Jun 2025 · 1 like Research-use-only status is a legal classification, not a safety classification. It means the compound is sold for laboratory use and not for human consumption. The…
-
Sequence verification for an obscure compound: how it is done Replied, post #63 · Compounds › Other compounds · 15 Jun 2025 · 0 likes Thymosin alpha-1 has a regulatory history in several jurisdictions and a real clinical literature, which puts it in a different evidential category from most of its…
-
Counter-ion content and its effect on measured mass Replied, post #59 · Analytics › Mass spectrometry · 8 Jun 2025 · 13 likes Adducts — sodium and potassium especially — shift the observed mass in predictable increments. A report showing an unexplained plus twenty-two is usually showing you a…
-
Second pass at: Pharmacy supply in the UK and the questions you will be asked Replied, post #36 · Regional › UK & Ireland · 10 May 2025 · 14 likes On post #34 — agreed on the reasoning, with one qualification. Supply and shortage resilience: both UK and Ireland sourced primarily from European suppliers until…
-
Reading a trial's population section before its results — does this still hold? Replied, post #77 · Evidence › Trials · 7 May 2025 · 0 likes Picking up post #76: that is the part I would want checked first. A comparator at less than its maximum licensed dose changes what a head-to-head result means. It does…
-
Telehealth prescribing models in the US Replied, post #83 · Regional › North America · 11 Apr 2025 · 0 likes Cross-border purchasing raises both a legal question and a practical one, and the legal one is yours to establish for your own jurisdiction.
-
What SELECT changed about how semaglutide is discussed, and what it did not Replied, post #67 · Compounds › Semaglutide · 7 Apr 2025 · 0 likes Taking post #64 at face value and following it one step further. Having read the whole SELECT thread before replying: the question in the first post has not actually…
-
Criticising the method without criticising the authors Replied, post #48 · Evidence › Study critique · 18 Mar 2025 · 5 likes Adding a data point of agreement rather than a data point.
-
Scheduled maintenance and what will be unavailable Replied, post #69 · Meta › Announcements · 11 Mar 2025 · 17 likes I read post #65 twice before replying, because I had assumed the opposite. My position on scheduled maintenance is current rather than settled. I have revised it once…
-
Adjudicated events and why the definition matters — the long version Replied, post #27 · Evidence › Trials · 28 Feb 2025 · 6 likes Answering the question post #25 raises rather than the one it answers. Multiplicity and multiple comparisons: if a trial tests many hypotheses, the chance of a false…
-
A supplier that answers analytical questions with restated claims Replied, post #24 · Sourcing › Red flags · 14 Feb 2025 · 16 likes Prices well below the rest of the market are a fact rather than a finding. They are worth noting and they do not establish anything on their own. That is all the detail…
-
Distinguishing a deletion sequence by mass alone Replied, post #31 · Analytics › Mass spectrometry · 30 Jan 2025 · 7 likes Calibration matters: a high-resolution instrument out of calibration can report mass with ppm error large enough to be uninformative. Check when the instrument was last…
-
Revisiting: Melanocortin agonists: mechanism and the documented adverse profile Replied, post #119 · Compounds › Other compounds · 16 Nov 2024 · 0 likes This follows post #118 rather than contradicting it. The most useful reply I ever got about Melanocortin agonists was a request to state my units. It sounds like…
-
Progressive overload when the scale is falling — one year on Replied, post #136 · Nutrition & Training › Resistance training · 8 Oct 2024 · 14 likes I will take the caveat as seriously as the claim, which is the point of putting it there.
-
Progressive overload when the scale is falling — one year on Replied, post #97 · Nutrition & Training › Resistance training · 27 Sep 2024 · 0 likes Confirming post #94 from a second method, which matters more than confirming it from a second person. Summarising the Progressive overload thread so far, since it is…
-
Second pass at: Sodium, potassium and magnesium when intake drops Replied, post #75 · Nutrition & Training › Hydration & electrolytes · 4 Sep 2024 · 0 likes Reading rather than answering, but this is the post I would point somebody at.
-
High-resolution MS on aggregates and what it can see — one year on Replied, post #2 · Analytics › Mass spectrometry · 8 Aug 2024 · 32 likes Picking up the opening post: that is the part I would want checked first. What mass accuracy establishes: the measured mass is consistent with a specific composition.…
-
Taste changes and food aversion, reported and discussed Replied, post #5 · Practice › Side effects · 26 Jul 2024 · 0 likes Adding a note of thanks rather than an opinion. I did not know most of that.
-
Circumference measurements as a poor man's composition estimate Replied, post #3 · Outcomes › Body composition · 16 Jul 2024 · 30 likes The opening post answers the question as asked. The question underneath it is different. Bone mineral density changes with substantial weight loss are measurable and…
-
Follow-up: What this community means by "a source", in practical terms Started this topic · Start Here › Welcome · 10 Jul 2024 · 10 likes The question in the title: What this community means by "a source", in practical terms I will give what I have already checked below so nobody repeats it. Counting it…
-
Where the four-week escalation interval comes from, and what it is not Replied, post #40 · Practice › Dosing & titration · 6 Jul 2024 · 3 likes The four-week step is a trial convention, not a pharmacological constant. It is roughly four half-lives for a week-long half-life, which is the interval at which you…